Περίληψη:
Background: To analyze data in terms of the glycaemic control and therapeutic regimens used for Type-2 Diabetes Mellitus (T2DM) management in Greece, identify factors that influence clinical decisions and determine the level of compliance of T2DM management with the latest international and local guidelines. Methods: 'AGREEMENT' was a national-multicenter, non-interventional, cross-sectional disease registry. A total of 1191 adult T2DM patients were enrolled consecutively from 59 sites of the National Health System (NHS) or University Hospitals, representing the majority of Diabetes centers or Diabetes outpatient clinics in Greece with a broad geographic distribution. Patients were stratified by gender and analysis was done according to 3 treatment strategies: A (lifestyle changes or use of one oral antidiabetic agent), B (up to 3 antidiabetic agents including injectables but not insulin) and C (any regimens with insulin). Results: Mean (±SD) HbA1c % of the total population was 7.1 (±1.2) while mean (±SD) FPG (mg/dl) was measured at 136 (±42). The proportion of patients who achieved HbA1c < 7% was 53% and ranged from 74.2% for group A, to 60.6% for group B and 35.5% for group C. Median age of the studied population was 65.0 year old (Interquartile Range-IQR 14.0) with an equal distribution of genders between groups. Patients on insulin therapy (treatment strategy C) were older (median age: 67 years vs 63 or 65 for A and B, respectively) with longer diabetes duration (mean duration: 15.3 years vs 5.2 and 10.1 for A and B, respectively). Patients who received insulin presented poor compliance. There was a consensus for a series of decision criteria and factors that potentially influence clinical decisions, used by physicians for selection of the therapeutic strategy among the three groups. Compliance with international and Greek guidelines received a high score among groups A, B and C. No significant differences were presented as per sites' geographic areas, NHS or University centers and physicians' specialty (endocrinologists, diabetologists and internists). Conclusions: The presented findings suggest the need for improvement of the glycaemic control rate, especially among insulin treated patients as this group seems to achieve low glycaemic control, by setting appropriate HbA1c targets along with timely and individualised intensification of treatment as well as post-therapy evaluation of the compliance with the proposed treatment. © 2019 The Author(s).
Συγγραφείς:
Liatis, S.
Iraklianou, S.
Kazakos, K.
Mastorakos, G.
Milios, K.
Mouslech, Z.
Noutsou, M.
Pagkalos, E.
Sampanis, C.
Zoi, A.
Olga, A.-K.
Eleni, A.
Iakovos, A.
Sofoklis, B.
Alexandra, B.
Christos, B.
Stavros, B.
Dimitrios, B.
Georgios, C.
Alexandra, C.
Triantafyllos, D.
George, D.
Eftihia, D.
Petros, D.
John, D.
Triada, E.
Maria, G.
Nikolaos, G.
Pinelopi, G.
Ioannis, I.
Evridiki, K.
Kostas, K.
Panagiotis, K.
Kalliopi, K.
Maria, K.
Leonidas, L.
Konstantinos, M.
Christos, M.
Georgios, M.
Andreas, M.
Ilias, M.
Asimina, M.
Stefanos, P.
Dimitrios, P.
Georgios, P.
Evangelos, P.
Ioannis, P.
Evangelos, R.
Maria, R.
Alexandra, R.
Christos, S.
Aimilios, S.
Dimitrios, S.
El Hasban, T.
Nikolaos, T.
Anastasia, T.
Apostolos, T.
Iraklis, T.
Apostolos, T.
Panagiotis, T.
Agathoklis, T.
Stefanos, T.
Glykeria, T.
Panagiotis, V.
Charalampos, V.
Anestis, V.
Andromachi, V.
Apostolos, X.
